Skip to search.
 FTSE 100 Down 0.03%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
7.63 Down 0.16(2.05%) 23 Sep 21:00
|After Hours: : 7.63 0.00 (0.00%) 23 Sep 21:47
Prev Close:7.79
Open:7.78
Bid:7.55 x 2500
Ask:7.75 x 2000
1y Target Est:12.75
Beta:1.40069
Earnings Date:1 Nov - 7 Nov (Est.)
Day's Range:7.55 - 7.94
52wk Range:4.98 - 14.48
Volume:1,949,682
Avg Vol (3m):2,295,260
Market Cap:1.08b
P/E (ttm):N/A
EPS (ttm):-1.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
FOLDDown 2.05%1.08b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.35
Quarterly EPS Est (Sep-16) :-0.32
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback